Formula Growth’s Procore PCOR Stock Holding History

Formula Growth’s Portfolio PCOR Stock Details PCOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,700	Closed	-$487K	–	151
2025 Q4	$487K	Sell	6,700 -7,300	-52%	-$540K	0.19%	118
2025 Q3	$1.02M	Buy	+14,000	New	+$978K	0.36%	91

Other funds holding PCOR

Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Formula Growth's PCOR Position: Q1 2026 in Review

Formula Growth sold out of Procore (PCOR) in Q1 2026, closing a stake of 6,700 shares — an estimated $487K sold.

Formula Growth first reported a position in PCOR in Q3 2025 and held it in 2 quarters. The position peaked at $1.02M in Q3 2025. 431 funds tracked by Wall St. Rank hold PCOR as of Q1 2026.

Formula Growth reported no remaining Procore position as of Q1 2026 after selling out during the quarter.
Formula Growth sold 6,700 Procore shares in Q1 2026, an estimated $487K.
Formula Growth first reported a position in Procore in Q3 2025 and held it in 2 quarters.
Formula Growth's Procore position peaked at $1.02M in Q3 2025.
431 funds tracked by Wall St. Rank held Procore as of Q1 2026.

Based on Formula Growth's 13F filing for Q1 2026, filed 14 May 2026.